ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
18.20
+0.12 (0.66%)
At close: Jun 27, 2025, 4:00 PM
18.76
+0.56 (3.08%)
After-hours: Jun 27, 2025, 7:23 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022
Period Ending
Dec '23 Dec '22
Needle-free Intranasal
30.00K
Log In
Needle-free Intranasal Growth
-97.72%
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022
Period Ending
Dec '23 Dec '22
United States
30.00K
Log In
United States Growth
-97.72%
Log In